Submission Details
| 510(k) Number | K112395 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 19, 2011 |
| Decision Date | September 09, 2011 |
| Days to Decision | 21 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K112395 is an FDA 510(k) clearance for the WONDFO PHENCYCLIDINE URINE TEST, TRICYCLIC ANTIDEPRESSANTS URINE TEST, a Radioimmunoassay, Tricyclic Antidepressant Drugs (Class II — Special Controls, product code LFG), submitted by Guangzhou Wondfo Biotech Co., Ltd. (Gaithersburg, US). The FDA issued a Cleared decision on September 9, 2011, 21 days after receiving the submission on August 19, 2011. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3910.
| 510(k) Number | K112395 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 19, 2011 |
| Decision Date | September 09, 2011 |
| Days to Decision | 21 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | LFG — Radioimmunoassay, Tricyclic Antidepressant Drugs |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3910 |
| Definition | Intended To Measure Any Of The Tricyclic Antidepressant Drugs In Serum Or Urine. |